- cafead Jun 25, 2018 at 12:52: PM
via So far, Roche’s Tecentriq hasn’t been able to find a piece of the lung cancer market to call its own. But that may change after its latest trial win.
article source
article source
-
Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page
With latest data, has Roche's Tecentriq found a blockbuster lung cancer niche?
- Thread starter cafead
- Start date
<
Similar threads